FDA NDC Directory · JSON-LD · Markdown

BENLYSTA

NDC 49401-088 · HUMAN PRESCRIPTION DRUG · SOLUTION

Generic namebelimumab
Labeler / ManufacturerGlaxoSmithKline LLC
Marketing categoryBiologic License Application · App BLA761043
Dosage form / routeSOLUTION · SUBCUTANEOUS
Active ingredientsBELIMUMAB (200 mg/mL)
Marketing started20170720
Package count5

External sources

Source: openFDA. Public-domain (CC0).